| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Finance &CAO | SVP, Finance | SVP, Finance
1 company
Cowan Elvia is a SVP, Finance &CAO at Vaxcyte, Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $1.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | PCVX Vaxcyte, Inc. | SVP, Finance &CAO | Sell | 1,892 | $55.57 | $105,146.98 | -3.1% | - | - | |
| Mar 11, 2026 | PCVX Vaxcyte, Inc. | SVP, Finance &CAO | Sale+OE | 2,500 | $58.59 | $146,481.75 | -7.5% | - | - | |
| Dec 23, 2025 | PCVX Vaxcyte, Inc. | SVP, Finance | Sell | 11,623 | $47.92 | $556,971.85 | -24.5% | +17.0% | - | |
| Sep 3, 2024 | PCVX Vaxcyte, Inc. | SVP, Finance | Sale+OE | 5,000 | $107.67 | $538,350.00 | -28.2% | -16.8% | -70.9% | |
| Jul 16, 2024 | PCVX Vaxcyte, Inc. | SVP, Finance | Sale+OE | 5,000 | $85.00 | $425,000.00 | -28.2% | +35.9% | -56.1% | |
| Jul 8, 2024 | PCVX Vaxcyte, Inc. | SVP, Finance | Sale+OE | 5,000 | $80.00 | $400,000.00 | -28.2% | +36.7% | -57.8% | |
| Mar 1, 2024 | PCVX Vaxcyte, Inc. | SVP, Finance | Sale+OE | 11,678 | $74.08 | $865,070.44 | -18.4% | -2.1% | +1.8% |